Dr. Kenneth Baillie

Biography

Professor Kenneth Baillie is a leading researcher at the Centre for Inflammation Research, focusing on the mechanisms underlying critical illness in patients, particularly through translational genomics. His research primarily encompasses areas such as sepsis and viral lung infections, with a significant emphasis on understanding the impact of oxygen deficiency on patients in intensive care. Baillie employs computational biology and host genomics to analyze diverse data sources, aiming to elucidate the molecular mechanisms that govern disease processes in critically ill patients, exploring ways to enhance survival and recovery rates. His notable contributions include leading the GenOMICC study, which aimed to uncover human genetic associations with susceptibility and outcomes related to critical illness, and resulted in identifying potential treatment options such as baricitinib for COVID-19 patients. Baillie has also pioneered innovative computational approaches like the Meta-Analysis Information Content (MAIC) methodology, facilitating the integration of data from various sources to enhance genomic research. Additionally, he has been actively involved in high altitude physiology studies and charity work focused on altitude medicine through the Apex organization.

Research Interests

Experience